Biohaven has purchased the 58% stake cancer immunotherapy developer Kleo Pharmaceuticals it did not already own.

Existing shareholder Biohaven has agreed to purchase the remaining stake in Kleo Pharmaceuticals, a Yale spinout it first backed in 2016.

Klingel subsidiary K-Invest is set to exit the online content analysis tool provider in a purchase of undisclosed size by peer Unicepta.

Advance Publications, Cisco, Intel, Fortinet and VMWare have exited the cloud security technology producer in a purchase by Entrust.

WPP has exited the television and video analytics provider in an acquisition by iSpot, with CEO Peter Daboll to become the latter's chief strategy officer.

American Family Insurance is set to acquire the insurance technology provider, one of its own portfolio companies.

You & Mr Jones has exited the digital ad payment platform in an acquisition by Integral Ad Science.

Dell Technologies Capital will exit the silicon chipmaker, which had raised $293m since it was founded less than two years ago.

The behavioural health assistance platform will get a public listing through the deal, which follows $110m from investors including SoftBank.

Heska has agreed to buy the R/GA-backed veterinary telemedicine platform developer in a deal set to close later this quarter.